Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease

References

• Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39(6):429–450.
   PubMed Web of Science ®Google Scholar
• Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997;115(6):808–815.
   PubMedGoogle Scholar
• Midena E, Angeli CD, Valenti M, De Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000;84(3):268–272.
   PubMed Web of Science ®Google Scholar
• Peksayar G, Altan-Yaycioglu R, Onal S. Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours. Eye (London, England). 2003;17(2):228–232.
   PubMed Web of Science ®Google Scholar
• Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea. 2002;21(1):12–16.
   PubMed Web of Science ®Google Scholar
• Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthal Plast Reconstr Surg. 2009;25(4):296–299.
   PubMed Web of Science ®Google Scholar
• Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997;104(12):2085–2093.
   PubMed Web of Science ®Google Scholar
• Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94(5):551–554.
   PubMed Web of Science ®Google Scholar
• Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon alpha2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117(12):2241–2246.
   PubMed Web of Science ®Google Scholar
• Karp CL, Galor A, Lee Y, Yoo SH. Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study. Ocul Immunol Inflamm. 2010;18(4):254–260.
   PubMed Web of Science ®Google Scholar
• Adler E, Turner JR, Stone DU. Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012. Cornea. 2013;32(12):1558–1561.
   PubMed Web of Science ®Google Scholar
• Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107(12):2190–2195.
   PubMed Web of Science ®Google Scholar
• Yeatts RP, Ford JG, Stanton CA, Reed JW. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 1995;102(9):1338–1344.
   PubMed Web of Science ®Google Scholar
• Kaimbo W, Kaimbo D, Parys-Van Ginderdeuren R, Missotten L. Conjunctival squamous cell carcinoma and intraepithelial neoplasia in AIDS patients in Congo Kinshasa. Bull Soc Belge Ophtalmol. 1998;268:135–141.
   PubMedGoogle Scholar
• Shields CL, Ramasubramanian A, Mellen PL, Shields JA. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection). Ophthalmology. 2011;118(11):2133–2137 e2131.
   PubMed Web of Science ®Google Scholar
• Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3–23.
   PubMed Web of Science ®Google Scholar
• Josephs DH, Spicer JF, Corrigan CJ, Gould HJ, Karagiannis SN. Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy. 2013;43(10):1110–1123.
   PubMed Web of Science ®Google Scholar
• Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60(9):1098–1111.
   PubMed Web of Science ®Google Scholar
• Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health. 2013;18(12):1424–1443.
   PubMed Web of Science ®Google Scholar
• Flynn TH, Manzouri B, Tuft SJ. Ocular surface squamous neoplasia in an immunosuppressed patient with atopic keratoconjunctivitis. Int Ophthalmol. 2012;32(5):471–473.
   PubMedGoogle Scholar
• Rundle P, Mudhar HS, Rennie I. Conjunctival intra-epithelial neoplasia occurring in young patients with asthma. Eye (Lond). 2010;24(7):1182–1185.
   PubMed Web of Science ®Google Scholar
• Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119(3):695–701.
   PubMed Web of Science ®Google Scholar
• Gichuhi S, Macharia E, Kabiru J, et al. Risk factors for ocular surface squamous neoplasia in Kenya: a case-control study. Trop Med Int Health. 2016;21(12):1522–1530.
   PubMed Web of Science ®Google Scholar
• Cipolat S, Hoste E, Natsuga K, Quist SR, Watt FM. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. Elife. 2014;3:e01888.
   PubMed Web of Science ®Google Scholar
• Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–446.
   PubMed Web of Science ®Google Scholar
• Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108(6):1093–1098.
   PubMed Web of Science ®Google Scholar
• Nanji AA, Sayyad FE, Karp CL. Topical chemotherapy for ocular surface squamous neoplasia. Curr Opin Ophthalmol. 2013;24(4):336–342.
   PubMed Web of Science ®Google Scholar
• Ramos MC, Mardegan MC, Peghini BC, Adad SJ, Michelin MA, Murta EF. Expression of cytokines in cervical stroma in patients with high-grade cervical intraepithelial neoplasia after treatment with intralesional interferon alpha-2b. Eur J Gynaecol Oncol. 2010;31(5):522–529.
   PubMed Web of Science ®Google Scholar
• Mardegan MC, Ramos MC, Adad SJ, Michelin MA, Shimba D, Murta EF. Immunological evaluation of vaginal secretion in patients with high-grade cervical intraepithelial neoplasia treated with intralesional interferon alpha-2b. Eur J Gynaecol Oncol. 2011;32(3):297–302.
   PubMed Web of Science ®Google Scholar
• Chakalova G, Ganchev G. Local administration of interferon-alpha in cases of cervical intraepithelial neoplasia associated with human papillomavirus infection. J Buon. 2004;9(4):399–402.
   PubMedGoogle Scholar
• Garzetti GG, Ciavattini A, Romanini C, et al. Interferon alpha 2b treatment of cervical intraepithelial neoplasia grade 2: modulation of natural killer cell. Gynecol Obstet Invest. 1994;37(3):204–209.
   PubMed Web of Science ®Google Scholar
• Munitz A, Levi-Schaffer F. Eosinophils: ‘new’ roles for ‘old’ cells. Allergy. 2004;59(3):268–275.
   PubMed Web of Science ®Google Scholar